Skip to main content

Table 1 GM/KM phenotypes in relation to IgG subclass-specific antibodies to PvMSP1-19 in subjects exposed to malaria

From: Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1

Phenotypes

(Number of subjects)

Antibody levels (Reactivity Index) (Median, Interquartile range)

 

IgG1

IgG2

IgG3

IgG4

GM 1,2,17 21 (9)

0.63(0.01-2.67)

0.05(0.01-0.21)

0.35(0.01-1.53)

0.01(0.01-0.18)

GM 1,17 5,13,14,21 (15)

0.87(0.55-1.97)

0.29(0.01-0.82)

1.66(0.01-6.31)

0.44(0.01-0.58)

GM 1,2,3,17 23 5,13,14,21 (13)

2.65(0.32-4.26)

0.33(0.01-0.46)

3.17(0.44-5.25)

0.11(0.01-0.48)

GM 1,3,17 23 5,13,14,21 (28)

0.76(0.01-3.57)

0.11(0.00-0.40)

d0.15(0.01-2.74)

0.09(0.01-0.52)

GM 1,3,17 23 5,6,13,14 (10)

1.88(1.49-3.37)

0.16(0.02-0.50)

0.47(0.02-2.40)

0.09(0.01-0.23)

GM 1,3,17 5,13,14,21 (18)

2.55(0.21-4.07)

0.31(0.06-1.54)

1.68(0.01-4.46)

f0.30(0.01-0.99)

GM 3 23 5,13,14 (20)

b3.60(1.89-4.71)

0.16(0.03-1.25)

2.49(0.25-5.81)

0.08(0.01-0.58)

aOther GM (71)

2.27(0.25-3.31)

0.28(0.01-0.67)

1.44(0.08-5.06)

0.17(0.01-0.43)

KM 1 (9)

1.18(0.01-2.44)

c0.02(0.01-0.16)

e0.01(0.01-2.35)

0.01(0.01-0.46)

KM 1,3 (68)

1.75(0.53-3.48)

0.18(0.00-0.64)

1.44(0.13-5.81)

0.19(0.01-0.56)

KM 3 (107)

2.32(0.18-3.86)

0.22(0.01-0.68)

1.53(0.06-3.83)

0.13(0.01-0.40)

  1. aOther GM [(GM 1,17 21 (n = 5), GM 1,17 5,6,14,21 (n = 5), GM 3 5,13,14 (n = 4), GM 1,17 13,21 (n = 5), GM 1,17 6,14,21 (n = 1), GM 1,2,17 13,21 (n = 4), GM 1,2,17 13,14,21 (n = 2), GM 1,3,17 13,14,21 (n = 1), GM 1,17 23 5,13,14,21 (n = 1), GM 1,17 5,6,13,14 (n = 4), GM 1,17 5,6,13,14,21 (n = 4), GM 1,17 5,14,21 (n = 2), GM 1,2,17 5,6,13,14,21 (n = 1), GM 1,2,17 5,6,14,21 (n = 4), GM 1,2,17 5,6,21 (n = 2), GM 1,2,3,17 5,6,13,14,21 (n = 1), GM 1,3,17 23 5,6,13,14,21 (n = 5), GM 1,3,17 5,13,14 (n = 4), GM 1,3,17 5,6,13,14 (n = 5), GM 1,3,17 5,6,13,14,21 (n = 3), GM 1,2,17 5,13,14,21 (n = 3), GM 1,2,3,17 5,13,14,21 (n = 5)]
  2. bsignificantly higher (P = 0.004), csignificantly lower (P = 0.031), dsignificantly lower (P = 0.051),
  3. esignificantly lower (P = 0.027), fsignificantly higher (P = 0.002), (obtained by Wilcoxon-Mann-Whitney test) compared with the rest of the GM phenotypes.